Harmony Biosciences (NASDAQ:HRMY) Research Coverage Started at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research note released on Tuesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $55.00 target price on the stock. A number of other research firms have also recently commented on HRMY. HC Wainwright reissued a “buy” […]
